Unknown

Dataset Information

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.


ABSTRACT: Expansion and differentiation of antigen-experienced PD-1+TCF-1+ stem-like CD8+ T cells into effector cells is critical for the success of immunotherapies based on PD-1 blockade1-4. Hashimoto et al. have shown that, in chronic infections, administration of the cytokine interleukin (IL)-2 triggers an alternative differentiation path of stem-like T cells towards a distinct population of 'better effector' CD8+ T cells similar to those generated in an acute infection5. IL-2 binding to the IL-2 receptor α-chain (CD25) was essential in triggering this alternative differentiation path and expanding better effectors with distinct transcriptional and epigenetic profiles. However, constitutive expression of CD25 on regulatory T cells

SUBMITTER: Codarri Deak L 

PROVIDER: S-EPMC9534752 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature